| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Puberty, Precocious | 9 | 2026 | 11 | 1.540 |
Why?
|
| Kisspeptins | 13 | 2025 | 25 | 1.380 |
Why?
|
| Brain Neoplasms | 13 | 2022 | 318 | 1.340 |
Why?
|
| Gonadotropin-Releasing Hormone | 18 | 2026 | 88 | 1.250 |
Why?
|
| Glioblastoma | 9 | 2022 | 160 | 1.050 |
Why?
|
| Glioma | 7 | 2012 | 101 | 0.980 |
Why?
|
| Luteinizing Hormone | 12 | 2026 | 101 | 0.810 |
Why?
|
| Neurons | 11 | 2026 | 933 | 0.800 |
Why?
|
| Stem Cells | 5 | 2010 | 276 | 0.730 |
Why?
|
| Sexual Maturation | 6 | 2022 | 52 | 0.730 |
Why?
|
| Receptors, G-Protein-Coupled | 8 | 2022 | 137 | 0.710 |
Why?
|
| Cell Movement | 10 | 2011 | 479 | 0.650 |
Why?
|
| Hydrocephalus, Normal Pressure | 4 | 2023 | 14 | 0.640 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2023 | 226 | 0.610 |
Why?
|
| Mice | 44 | 2026 | 11085 | 0.600 |
Why?
|
| Mutation, Missense | 7 | 2026 | 190 | 0.590 |
Why?
|
| Hydrocephalus | 3 | 2023 | 41 | 0.560 |
Why?
|
| Animals | 53 | 2026 | 21286 | 0.530 |
Why?
|
| Mice, Nude | 14 | 2012 | 287 | 0.520 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 1564 | 0.510 |
Why?
|
| Mutation | 10 | 2025 | 2657 | 0.490 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2019 | 203 | 0.490 |
Why?
|
| Follicle Stimulating Hormone, beta Subunit | 5 | 2022 | 6 | 0.490 |
Why?
|
| Meningioma | 4 | 2012 | 63 | 0.470 |
Why?
|
| Pituitary Neoplasms | 3 | 2025 | 21 | 0.470 |
Why?
|
| Hypogonadism | 6 | 2022 | 15 | 0.420 |
Why?
|
| Hypothalamus | 5 | 2023 | 133 | 0.390 |
Why?
|
| Estradiol | 6 | 2026 | 259 | 0.350 |
Why?
|
| Male | 39 | 2026 | 30942 | 0.340 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2010 | 234 | 0.330 |
Why?
|
| Humans | 55 | 2026 | 64934 | 0.320 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 3 | 2022 | 10 | 0.320 |
Why?
|
| DNA Copy Number Variations | 3 | 2025 | 72 | 0.310 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 7 | 0.310 |
Why?
|
| Transfection | 4 | 2010 | 701 | 0.310 |
Why?
|
| Receptors, Peptide | 3 | 2022 | 34 | 0.300 |
Why?
|
| Fertility | 4 | 2022 | 84 | 0.300 |
Why?
|
| Tropism | 2 | 2006 | 15 | 0.300 |
Why?
|
| Stromal Cells | 1 | 2009 | 78 | 0.290 |
Why?
|
| Drug Delivery Systems | 4 | 2022 | 333 | 0.290 |
Why?
|
| Female | 36 | 2026 | 33915 | 0.290 |
Why?
|
| Membrane Proteins | 4 | 2023 | 918 | 0.290 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 237 | 0.290 |
Why?
|
| Substance P | 3 | 2021 | 43 | 0.270 |
Why?
|
| Gene Expression Regulation | 9 | 2023 | 1629 | 0.260 |
Why?
|
| Telomerase | 1 | 2007 | 30 | 0.260 |
Why?
|
| Receptors, LHRH | 4 | 2022 | 8 | 0.260 |
Why?
|
| Ovary | 2 | 2026 | 105 | 0.250 |
Why?
|
| Medulloblastoma | 1 | 2006 | 13 | 0.250 |
Why?
|
| Neurokinin A | 2 | 2017 | 4 | 0.240 |
Why?
|
| Remission Induction | 1 | 2006 | 149 | 0.240 |
Why?
|
| Gene Targeting | 1 | 2006 | 77 | 0.240 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2026 | 15 | 0.240 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2025 | 12 | 0.240 |
Why?
|
| Chromogranins | 2 | 2025 | 12 | 0.240 |
Why?
|
| Chorionic Gonadotropin | 2 | 2023 | 15 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 205 | 0.230 |
Why?
|
| Vasopressins | 1 | 2025 | 15 | 0.230 |
Why?
|
| Arginine Vasopressin | 1 | 2025 | 20 | 0.230 |
Why?
|
| Ribonucleoproteins | 3 | 2023 | 116 | 0.230 |
Why?
|
| Cell Survival | 5 | 2010 | 587 | 0.230 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 29 | 0.230 |
Why?
|
| Cell Line | 9 | 2022 | 2020 | 0.230 |
Why?
|
| Meningeal Neoplasms | 3 | 2012 | 62 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 4 | 2019 | 286 | 0.230 |
Why?
|
| Prolactinoma | 1 | 2025 | 4 | 0.230 |
Why?
|
| HEK293 Cells | 8 | 2022 | 615 | 0.220 |
Why?
|
| Estrogen Receptor alpha | 1 | 2025 | 49 | 0.220 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1036 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 148 | 0.220 |
Why?
|
| Adenoma | 1 | 2025 | 69 | 0.220 |
Why?
|
| Oxytocin | 1 | 2025 | 44 | 0.220 |
Why?
|
| Sex Characteristics | 2 | 2025 | 211 | 0.210 |
Why?
|
| Reproduction | 2 | 2015 | 98 | 0.210 |
Why?
|
| Gonadotropins | 2 | 2022 | 14 | 0.210 |
Why?
|
| Mice, Knockout | 10 | 2022 | 2152 | 0.210 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 5 | 2020 | 18 | 0.210 |
Why?
|
| Mullerian Ducts | 1 | 2023 | 5 | 0.210 |
Why?
|
| Adenylate Kinase | 1 | 2023 | 18 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 542 | 0.200 |
Why?
|
| Infertility | 1 | 2023 | 30 | 0.200 |
Why?
|
| Cyclic AMP Response Element Modulator | 2 | 2016 | 3 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 642 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 82 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2022 | 3141 | 0.190 |
Why?
|
| Infertility, Female | 2 | 2015 | 47 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2187 | 0.180 |
Why?
|
| Gonadotrophs | 1 | 2022 | 5 | 0.180 |
Why?
|
| Proteostasis | 1 | 2022 | 11 | 0.180 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Fibrinolysin | 1 | 2021 | 6 | 0.180 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2021 | 5 | 0.180 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2022 | 52 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 160 | 0.170 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2012 | 6 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 449 | 0.170 |
Why?
|
| Receptors, Kisspeptin-1 | 6 | 2015 | 10 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 2240 | 0.160 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2019 | 30 | 0.160 |
Why?
|
| Peptide Fragments | 6 | 2021 | 417 | 0.160 |
Why?
|
| Immunohistochemistry | 7 | 2012 | 895 | 0.160 |
Why?
|
| Stuttering | 1 | 2019 | 3 | 0.160 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2011 | 39 | 0.150 |
Why?
|
| Genetic Therapy | 1 | 2006 | 837 | 0.150 |
Why?
|
| Leptin | 2 | 2021 | 88 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 3 | 2013 | 401 | 0.140 |
Why?
|
| Infertility, Male | 2 | 2015 | 58 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2018 | 4 | 0.140 |
Why?
|
| Neurokinin B | 4 | 2022 | 5 | 0.140 |
Why?
|
| Neuropeptides | 2 | 2015 | 81 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2017 | 29 | 0.130 |
Why?
|
| Receptors, Neurokinin-3 | 2 | 2015 | 2 | 0.130 |
Why?
|
| Thyroid Diseases | 1 | 2017 | 30 | 0.130 |
Why?
|
| Paternal Inheritance | 1 | 2017 | 7 | 0.130 |
Why?
|
| RNA, Messenger | 8 | 2023 | 1575 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2017 | 48 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 428 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 140 | 0.130 |
Why?
|
| Puberty | 3 | 2023 | 59 | 0.120 |
Why?
|
| Child | 6 | 2026 | 4606 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2021 | 513 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 156 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 42 | 0.120 |
Why?
|
| COS Cells | 4 | 2022 | 180 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 46 | 0.120 |
Why?
|
| Receptors, Neuropeptide | 1 | 2015 | 3 | 0.120 |
Why?
|
| Adamantane | 1 | 2015 | 5 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2006 | 52 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2015 | 6 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2020 | 907 | 0.120 |
Why?
|
| Neurosecretory Systems | 1 | 2015 | 24 | 0.110 |
Why?
|
| Dipeptides | 1 | 2015 | 68 | 0.110 |
Why?
|
| Administration, Intravenous | 2 | 2025 | 71 | 0.110 |
Why?
|
| Adult | 9 | 2025 | 17306 | 0.110 |
Why?
|
| Pituitary Diseases | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2026 | 3468 | 0.110 |
Why?
|
| Middle Aged | 9 | 2025 | 18203 | 0.110 |
Why?
|
| Arrestins | 1 | 2014 | 10 | 0.110 |
Why?
|
| Puberty, Delayed | 1 | 2014 | 3 | 0.110 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 2281 | 0.110 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 15 | 0.110 |
Why?
|
| ErbB Receptors | 2 | 2012 | 127 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2014 | 30 | 0.110 |
Why?
|
| Hemopexin | 2 | 2005 | 5 | 0.110 |
Why?
|
| Polymers | 2 | 2010 | 332 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2021 | 311 | 0.100 |
Why?
|
| Platelet Factor 4 | 2 | 2005 | 12 | 0.100 |
Why?
|
| GABAergic Neurons | 1 | 2014 | 38 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 138 | 0.100 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 29 | 0.100 |
Why?
|
| Alcoholism | 1 | 2016 | 327 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 180 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2012 | 138 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 45 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 367 | 0.100 |
Why?
|
| Sex Factors | 3 | 2025 | 991 | 0.090 |
Why?
|
| Tachykinins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 94 | 0.090 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 9 | 0.090 |
Why?
|
| Brain | 4 | 2023 | 1600 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 3 | 2012 | 426 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 59 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2013 | 163 | 0.090 |
Why?
|
| Protein Precursors | 1 | 2012 | 85 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2019 | 710 | 0.090 |
Why?
|
| Chromosomal Instability | 1 | 2012 | 20 | 0.090 |
Why?
|
| Ovulation | 2 | 2026 | 28 | 0.090 |
Why?
|
| Dextrans | 1 | 2011 | 45 | 0.090 |
Why?
|
| Neoplasm Staging | 3 | 2010 | 540 | 0.090 |
Why?
|
| Magnetite Nanoparticles | 1 | 2011 | 29 | 0.090 |
Why?
|
| Luciferases | 1 | 2011 | 107 | 0.090 |
Why?
|
| Neoplasm Transplantation | 3 | 2010 | 168 | 0.080 |
Why?
|
| Iron | 1 | 2011 | 150 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 195 | 0.080 |
Why?
|
| Pedigree | 3 | 2017 | 193 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 94 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 875 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2022 | 541 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 3 | 2018 | 86 | 0.080 |
Why?
|
| Inositol Phosphates | 3 | 2015 | 17 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 37 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2010 | 44 | 0.080 |
Why?
|
| Chemotaxis | 2 | 2009 | 50 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2009 | 207 | 0.080 |
Why?
|
| Doxorubicin | 1 | 2010 | 98 | 0.080 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2009 | 6 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2023 | 1551 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2009 | 17 | 0.070 |
Why?
|
| Stem Cell Transplantation | 2 | 2009 | 79 | 0.070 |
Why?
|
| Stem Cell Niche | 1 | 2009 | 18 | 0.070 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2009 | 42 | 0.070 |
Why?
|
| Microvessels | 1 | 2009 | 18 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 210 | 0.070 |
Why?
|
| Tissue Scaffolds | 1 | 2010 | 90 | 0.070 |
Why?
|
| Umbilical Veins | 2 | 2005 | 13 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2025 | 2612 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2010 | 148 | 0.070 |
Why?
|
| Uterus | 2 | 2023 | 41 | 0.070 |
Why?
|
| Transgenes | 1 | 2009 | 204 | 0.070 |
Why?
|
| Neurofibromin 2 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2007 | 585 | 0.070 |
Why?
|
| Aged | 6 | 2025 | 14917 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 53 | 0.070 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 793 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2021 | 128 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 89 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 267 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2013 | 610 | 0.060 |
Why?
|
| Neoplasms | 1 | 2017 | 1364 | 0.060 |
Why?
|
| Protein Transport | 2 | 2022 | 404 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2007 | 16 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cytosine Deaminase | 1 | 2006 | 6 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 59 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2006 | 25 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 509 | 0.060 |
Why?
|
| Protein Binding | 3 | 2021 | 1639 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2015 | 491 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 277 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 99 | 0.060 |
Why?
|
| Proestrus | 1 | 2026 | 4 | 0.060 |
Why?
|
| Biological Factors | 1 | 2006 | 19 | 0.060 |
Why?
|
| Laminin | 1 | 2006 | 81 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2022 | 505 | 0.060 |
Why?
|
| Phenotype | 3 | 2015 | 1231 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 583 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 218 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2025 | 159 | 0.060 |
Why?
|
| Cell Division | 2 | 2004 | 449 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2005 | 41 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2005 | 104 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2026 | 2052 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 136 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2005 | 25 | 0.060 |
Why?
|
| Progesterone | 1 | 2026 | 165 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2025 | 24 | 0.060 |
Why?
|
| Linear Models | 1 | 2006 | 405 | 0.060 |
Why?
|
| Young Adult | 2 | 2025 | 4793 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2025 | 67 | 0.060 |
Why?
|
| Polyglycolic Acid | 1 | 2005 | 18 | 0.060 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2025 | 61 | 0.050 |
Why?
|
| Genome, Human | 1 | 2006 | 237 | 0.050 |
Why?
|
| Cricetulus | 2 | 2015 | 103 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2005 | 75 | 0.050 |
Why?
|
| CHO Cells | 2 | 2015 | 192 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2015 | 80 | 0.050 |
Why?
|
| Endostatins | 1 | 2004 | 4 | 0.050 |
Why?
|
| Telencephalon | 1 | 2004 | 10 | 0.050 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 16 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 394 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 178 | 0.050 |
Why?
|
| Genomics | 1 | 2007 | 383 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2005 | 373 | 0.050 |
Why?
|
| Cell Growth Processes | 3 | 2010 | 36 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2004 | 37 | 0.050 |
Why?
|
| Choroid Plexus | 1 | 2023 | 15 | 0.050 |
Why?
|
| Microcirculation | 1 | 2004 | 59 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 414 | 0.050 |
Why?
|
| Ependyma | 1 | 2023 | 9 | 0.050 |
Why?
|
| Endometrium | 1 | 2023 | 31 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2014 | 198 | 0.050 |
Why?
|
| Testosterone | 2 | 2018 | 128 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2004 | 108 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2005 | 154 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 120 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 856 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2013 | 96 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 852 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 687 | 0.050 |
Why?
|
| Pituitary Gland | 2 | 2016 | 50 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 132 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 117 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 176 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2013 | 56 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 447 | 0.050 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2022 | 4 | 0.050 |
Why?
|
| Castration | 1 | 2022 | 43 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 297 | 0.050 |
Why?
|
| Alleles | 1 | 2023 | 453 | 0.040 |
Why?
|
| Cilia | 1 | 2023 | 156 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2022 | 65 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5775 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 87 | 0.040 |
Why?
|
| Disease Progression | 3 | 2012 | 1214 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2023 | 410 | 0.040 |
Why?
|
| Time Factors | 2 | 2010 | 3753 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2022 | 176 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2013 | 960 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 153 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 324 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 698 | 0.040 |
Why?
|
| Catheter Obstruction | 1 | 2019 | 2 | 0.040 |
Why?
|
| Peptides | 2 | 2015 | 588 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 2019 | 15 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2019 | 15 | 0.040 |
Why?
|
| Drainage | 1 | 2019 | 152 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 622 | 0.040 |
Why?
|
| Lipids | 1 | 2021 | 327 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 105 | 0.040 |
Why?
|
| Apoptosis | 1 | 2004 | 1100 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 300 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 88 | 0.040 |
Why?
|
| Nitrosative Stress | 1 | 2018 | 1 | 0.030 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2018 | 3 | 0.030 |
Why?
|
| Sperm Count | 1 | 2018 | 14 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 764 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2019 | 135 | 0.030 |
Why?
|
| Thyrotoxicosis | 1 | 2017 | 7 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 297 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1383 | 0.030 |
Why?
|
| RNA | 1 | 2021 | 426 | 0.030 |
Why?
|
| Microspheres | 2 | 2010 | 55 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 22 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 2017 | 43 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 102 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 160 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 128 | 0.030 |
Why?
|
| DNA | 1 | 2021 | 857 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 641 | 0.030 |
Why?
|
| RNA Interference | 2 | 2010 | 643 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2371 | 0.030 |
Why?
|
| Luteinizing Hormone, beta Subunit | 1 | 2016 | 3 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2016 | 46 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 58 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2015 | 24 | 0.030 |
Why?
|
| Gonadotropins, Pituitary | 1 | 2015 | 3 | 0.030 |
Why?
|
| Biopsy | 2 | 2007 | 454 | 0.030 |
Why?
|
| Genitalia, Male | 1 | 2015 | 11 | 0.030 |
Why?
|
| Genitalia, Female | 1 | 2015 | 16 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 2015 | 59 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 103 | 0.030 |
Why?
|
| PubMed | 1 | 2015 | 11 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2015 | 36 | 0.030 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 34 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2015 | 76 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2015 | 86 | 0.030 |
Why?
|
| Ipilimumab | 1 | 2014 | 8 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2015 | 134 | 0.030 |
Why?
|
| Receptors, Tachykinin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 74 | 0.030 |
Why?
|
| beta-Arrestin 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Buserelin | 1 | 2014 | 1 | 0.030 |
Why?
|
| beta-Arrestin 2 | 1 | 2014 | 2 | 0.030 |
Why?
|
| beta-Arrestins | 1 | 2014 | 5 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2015 | 142 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 122 | 0.030 |
Why?
|
| Fathers | 1 | 2014 | 22 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2014 | 20 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2014 | 49 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 463 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 414 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 129 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2013 | 83 | 0.020 |
Why?
|
| Cattle | 2 | 2005 | 320 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2016 | 6840 | 0.020 |
Why?
|
| Exome | 1 | 2013 | 69 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 362 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 181 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 173 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2012 | 6 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 154 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2012 | 10 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2005 | 869 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1103 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 581 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 391 | 0.020 |
Why?
|
| Glycosylation | 1 | 2012 | 138 | 0.020 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2012 | 28 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 156 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1476 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 94 | 0.020 |
Why?
|
| Software | 1 | 2015 | 394 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1979 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 197 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 920 | 0.020 |
Why?
|
| Melanoma | 1 | 2014 | 332 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 342 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2012 | 189 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 676 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 268 | 0.020 |
Why?
|
| Models, Biological | 2 | 2007 | 1192 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 25 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 662 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 29 | 0.020 |
Why?
|
| Acrylamides | 1 | 2010 | 13 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 49 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 71 | 0.020 |
Why?
|
| Fibrin | 1 | 2010 | 19 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 75 | 0.020 |
Why?
|
| Printing | 1 | 2010 | 21 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2010 | 213 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 62 | 0.020 |
Why?
|
| Lasers | 1 | 2010 | 37 | 0.020 |
Why?
|
| Methacrylates | 1 | 2010 | 41 | 0.020 |
Why?
|
| Response Elements | 1 | 2009 | 44 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 2010 | 38 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2009 | 29 | 0.020 |
Why?
|
| Drug Stability | 1 | 2010 | 144 | 0.020 |
Why?
|
| Liposomes | 1 | 2010 | 116 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2010 | 144 | 0.020 |
Why?
|
| Estrous Cycle | 1 | 2009 | 12 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 195 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 173 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 113 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 673 | 0.020 |
Why?
|
| Hydrogels | 1 | 2010 | 127 | 0.020 |
Why?
|
| Neurofibromatosis 2 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2007 | 44 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 301 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2007 | 9 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2007 | 38 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 240 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2007 | 261 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 100 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 130 | 0.020 |
Why?
|
| Multigene Family | 1 | 2006 | 106 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 213 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1287 | 0.010 |
Why?
|
| Coagulants | 1 | 2005 | 3 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 108 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 951 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 7 | 0.010 |
Why?
|
| Software Validation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 33 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2004 | 19 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1329 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 730 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2003 | 6 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 6292 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1691 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 555 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 710 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 372 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1589 | 0.010 |
Why?
|